Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Cells|January 30, 2020
Tumor-Educated Platelets and Angiogenesis in Glioblastoma: Another Brick in the Wall for Novel Prognostic and Targetable Biomarkers, Changing the Vision from a Localized Tumor to a Systemic PathologyRolando Campanella, Laura Guarnaccia, Chiara Cordiglieri, et al.
Life Science Alliance|February 15, 2019
Mucosa-associated microbiota drives pathogenic functions in IBD-derived intestinal iNKT cellsClaudia Burrello, Gabriella Pellegrino, Maria Rita Giuffrè, et al.
Cell Death & Disease|January 7, 2018
The epigenetically regulated miR-494 associates with stem-cell phenotype and induces sorafenib resistance in hepatocellular carcinomaDaniela Pollutri, Clarissa Patrizi, Sara Marinelli, et al.
Journal of Autoimmunity|April 15, 2020
CXCL4 triggers monocytes and macrophages to produce PDGF-BB, culminating in fibroblast activation: Implications for systemic sclerosisMaarten van der Kroef, Tiago Carvalheiro, Marzia Rossato, et al.
Journal of Crohn'S & Colitis|April 27, 2018
Pathogenicity of In Vivo Generated Intestinal Th17 Lymphocytes is IFNγ DependentGiulia Nizzoli, Claudia Burrello, Fulvia Milena Cribiù, et al.
Blood Transfusion = Trasfusione Del Sangue|August 15, 2022
Neonatal alloimmune neutropenia: diagnosis and management of 31 Italian patientsAlessandra Cattaneo, Manuela Liguori, Elena Trombetta, et al.
JHEP Reports : Innovation in Hepatology|October 27, 2025
Artificial intelligence as a ploy to delve into the intricate link between genetics and mitochondria in patients with MASLDMiriam Longo, Erika Paolini, Marica Meroni, et al.
Frontiers in Immunology|December 28, 2020
Early Phases of COVID-19 Are Characterized by a Reduction in Lymphocyte Populations and the Presence of Atypical MonocytesAndrea Lombardi, Elena Trombetta, Alessandra Cattaneo, et al.
Scientific Reports|March 2, 2021
Impact of SARS-CoV-2 infection on the recovery of peripheral blood mononuclear cells by density gradientMaria D I Manunta, Giuseppe Lamorte, Francesca Ferrari, et al.
Journal of Hepatology|July 15, 2019
Excellent safety and effectiveness of high-dose myrcludex-B monotherapy administered for 48 weeks in HDV-related compensated cirrhosis: A case report of 3 patientsAlessandro Loglio, Peter Ferenci, Sara Colonia Uceda Renteria, et al.
Pageof 5